Mayeux R - Search Results

1

Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer's disease.

Sano M, Bell K, Cote L, Dooneief G, Lawton A, Legler L, Marder K, Naini A, Stern Y, Mayeux R. Sano M, et al. Among authors: mayeux r. Arch Neurol. 1992 Nov;49(11):1137-41. doi: 10.1001/archneur.1992.00530350051019. Arch Neurol. 1992. PMID: 1444880 Clinical Trial.

2

Long-term administration of oral physostigmine in Alzheimer's disease.

Stern Y, Sano M, Mayeux R. Stern Y, et al. Among authors: mayeux r. Neurology. 1988 Dec;38(12):1837-41. doi: 10.1212/wnl.38.12.1837. Neurology. 1988. PMID: 3057398 Clinical Trial.

3

An estimate of the prevalence of dementia in idiopathic Parkinson's disease.

Mayeux R, Stern Y, Rosenstein R, Marder K, Hauser A, Cote L, Fahn S. Mayeux R, et al. Arch Neurol. 1988 Mar;45(3):260-2. doi: 10.1001/archneur.1988.00520270034017. Arch Neurol. 1988. PMID: 3341950

4

Cerebral perfusion as a diagnostic marker of early Alzheimer's disease.

Prohovnik I, Mayeux R, Sackeim HA, Smith G, Stern Y, Alderson PO. Prohovnik I, et al. Among authors: mayeux r. Neurology. 1988 Jun;38(6):931-7. doi: 10.1212/wnl.38.6.931. Neurology. 1988. PMID: 3368076

5

Predictors of disease course in patients with probable Alzheimer's disease.

Stern Y, Mayeux R, Sano M, Hauser WA, Bush T. Stern Y, et al. Among authors: mayeux r. Neurology. 1987 Oct;37(10):1649-53. doi: 10.1212/wnl.37.10.1649. Neurology. 1987. PMID: 3658173

6

Effects of oral physostigmine in Alzheimer's disease.

Stern Y, Sano M, Mayeux R. Stern Y, et al. Among authors: mayeux r. Ann Neurol. 1987 Sep;22(3):306-10. doi: 10.1002/ana.410220305. Ann Neurol. 1987. PMID: 3674795 Clinical Trial.

7

The frequency and associated risk factors for dementia in patients with Parkinson's disease.

Marder K, Tang MX, Cote L, Stern Y, Mayeux R. Marder K, et al. Among authors: mayeux r. Arch Neurol. 1995 Jul;52(7):695-701. doi: 10.1001/archneur.1995.00540310069018. Arch Neurol. 1995. PMID: 7619026

8

Neuropsychological characteristics of preclinical dementia in Parkinson's disease.

Jacobs DM, Marder K, Côté LJ, Sano M, Stern Y, Mayeux R. Jacobs DM, et al. Among authors: mayeux r. Neurology. 1995 Sep;45(9):1691-6. doi: 10.1212/wnl.45.9.1691. Neurology. 1995. PMID: 7675228

9

The age at onset of Alzheimer's disease and an intracranial area measurement. A relationship.

Schofield PW, Mosesson RE, Stern Y, Mayeux R. Schofield PW, et al. Among authors: mayeux r. Arch Neurol. 1995 Jan;52(1):95-8. doi: 10.1001/archneur.1995.00540250103019. Arch Neurol. 1995. PMID: 7826282

10

Comparison of cognitive changes in patients with Alzheimer's and Parkinson's disease.

Stern Y, Richards M, Sano M, Mayeux R. Stern Y, et al. Among authors: mayeux r. Arch Neurol. 1993 Oct;50(10):1040-5. doi: 10.1001/archneur.1993.00540100035011. Arch Neurol. 1993. PMID: 8215961

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

697 results

Search Page

Filters